Sien Yee Lau

Sien Yee Lau

Auto-generated profile, based on publicly available information

Sien Yee Lau

Department of Obstetric, Gynecologic & Reproductive Science, University of Auckland, Auckland, New Zealand

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 June 2013 in American Journal of Reproductive Immunology
Verified
Journal Article
Closed access
SLSien Yee Lau
Sien Yee Lau
SGSarah-Jane Guild
Sarah-Jane Guild
CBCarolyn J. Barrett
Carolyn J. Barrett
QCQi Chen
Qi Chen
LMLeslie McCowan
Leslie McCowan
LCLarry W Chamley
Larry W Chamley

1 December 2012 in Cytokine
Verified
Journal Article
Closed access
JXJ.P. Xiao
J.P. Xiao
YYY.X. Yin
Y.X. Yin
YGY.F. Gao
Y.F. Gao
SLS. Lau
S. Lau
FSF. Shen
F. Shen
QCQ. Chen
Q. Chen

1 July 2012 in Placenta
Verified
Journal Article
Closed access
Qi ChenQi Chen
Qi Chen
FGF. Guo
F. Guo
HJH.Y. Jin
H.Y. Jin
SLS. Lau
S. Lau
DBDebbie Beaumont
Debbie Beaumont
LCLarry W Chamley
Larry W Chamley

1 June 2014 in European Journal of Obstetrics & Gynecology and Reproductive Biology
Verified
Journal Article
Closed access
XLX.L. Li
X.L. Li
TCT.T. Chen
T.T. Chen
XDX. Dong
X. Dong
WGW.L. Gou
W.L. Gou
SLS. Lau
S. Lau
Qi ChenQi Chen
Qi Chen

1 August 2023 in Disease Models & Mechanisms
Verified
Journal Article
Open access
PDF file
SLSien Yee Lau
Sien Yee Lau
MKMatthew Kang
Matthew Kang
CHColin Lee Hisey
Colin Lee Hisey
LCLarry W Chamley
Larry W Chamley
Extracellular vesicles (EVs) are lipid-bound vesicles released from cells that play a crucial role in many physiological processes and pathological mechanisms. As such, there is great interest in their biodistribution. One currently accessible technology to study their fate in vivo involves fluorescent labelling of exogenous EVs followed by whole-animal imaging. Although this is not a new technology, its translation from studying the fate of whole cells to subcellular EVs requires adaptation of the labelling techniques, excess dye removal and a refined experimental design. In this Review, we detail the methods and considerations for using fluorescence in vivo and ex vivo imaging to study the biodistribution of exogenous EVs and their roles in physiology and disease biology.

1 January 2015 in Journal of Cancer
Verified
Journal Article
Open access
Qi ChenQi Chen
Qi Chen
Mancy TongMancy Tong
Mancy Tong
FGFang Guo
Fang Guo
SLSandy Lau
Sandy Lau
MZMin Zhao
Min Zhao
Parity is one of well-known risk factors of endometrial cancer, but it is less clear whether parity is associated with the timing of developing endometrial cancer, and with the incidence of subtype of endometrial cancer. Data on 902 patients including age at diagnosis, age at menarche and menopause, parity and age at last birth from two obstetrics and gynaecology hospitals in China was analysed. 5.6% patients were nulliparous, 53.4% patients had one live birth, 27.7% patients had two live births and 13.3% patients had three or more live births. Patients at diagnosis who had three or more live births were significantly older than patients who were nulliparous or had one or two live births with the median age at diagnosis of 63 versus 51 or 52 or 59 years respectively. The percentage of patients with three or more live births at diagnosis before menopause was significantly lower than patients who were nulliparous, had one live birth or had two live births (10% versus 52%, or 51.9% or 22.4%). Furthermore, time from last birth to endometrial cancer was significantly longer in patients who had three or more live births than patients who had two live births or had one live birth (35 versus 31, or 24 years). However, there was no difference in the incidence of subtypes of endometrial cancer according to parity. Our data suggests parity is negatively correlated with the time onset of endometrial cancer and not associated with the incidence of endometrial cancer subtypes.